Xie et al., 2024 - Google Patents
Design, synthesis, and cell-based in vitro assay of deoxyinosine-mixed SATE-dCDN prodrugs that activate all common STING variantsXie et al., 2024
- Document ID
- 4524300280953089616
- Author
- Xie Z
- Yang Y
- Ma D
- Xi Z
- Publication year
- Publication venue
- Organic & Biomolecular Chemistry
External Links
Snippet
Developing therapeutic strategies to modulate the activity of all prevalent variants (wild-type, HAQ, R232H, AQ, and R293Q) of the stimulator of interferon genes (STING) is still of great interest to treating immune-related diseases. Herein, we synthesized six novel deoxyinosine …
- 229940002612 prodrug 0 title abstract description 116
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulfur or nitrogen atom directly attached in position 2 or 6, but not in both
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11667664B2 (en) | Cyclic dinucleotides for cytokine induction | |
| US10981919B2 (en) | Selective PI3K delta inhibitors | |
| Herdewijn et al. | 3'-Substituted 2', 3'-dideoxynucleoside analogs as potential anti-HIV (HTLV-III/LAV) agents | |
| Wang et al. | Synthesis and biological evaluation of all possible inosine-mixed cyclic dinucleotides that activate different hSTING variants | |
| Schwede et al. | The chemistry of the noncanonical cyclic dinucleotide 2′ 3′-cGAMP and its analogs | |
| Hernández et al. | Acyclic nucleoside analogues as novel inhibitors of human mitochondrial thymidine kinase | |
| Xie et al. | Design, synthesis, and cell-based in vitro assay of deoxyinosine-mixed SATE-dCDN prodrugs that activate all common STING variants | |
| Ottria et al. | Synthesis and evaluation of in vitro anticancer activity of some novel isopentenyladenosine derivatives | |
| Ma et al. | Design and synthesis of cyclic dinucleotide analogues containing triazolyl C-nucleosides | |
| CN117916234A (en) | Compounds as TYK2/JAK1 pseudokinase domain inhibitors and methods of synthesis and use | |
| Porcari et al. | Deoxy sugar analogues of triciribine: correlation of antiviral and antiproliferative activity with intracellular phosphorylation | |
| Ali et al. | Activity of nicotinic acid substituted nicotinic acid adenine dinucleotide phosphate (NAADP) analogs in a human cell line: difference in specificity between human and sea urchin NAADP receptors | |
| Guseva et al. | AMPK-specific autophagy activator based on 1, 3-diaza-2-oxophenoxazine | |
| Slusarczyk et al. | Symmetrical Diamidates as a Class of Phosphate Prodrugs to Deliver the 5′‐Monophosphate Forms of Anticancer Nucleoside Analogues | |
| CA3246792A1 (en) | Nucleoside line-1 inhibitors | |
| WO2015197655A1 (en) | Methods and products from the reaction of tetrazines with nucleic acid polymers bearing ethenyl aromatic groups | |
| Knies et al. | Ameliorated or Acquired Cytostatic/Cytotoxic Properties of Nucleosides by Lipophilization | |
| Stazzoni | Design and synthesis of clickable nucleic acid analogues for cancer therapy and diagnosis | |
| WO2025054460A1 (en) | Phosphodiesterase-stable endo-phosphorothioate- substituted 2'3'-cgamp analogues as agonists of stimulator of interferon gene | |
| WO2021262548A1 (en) | A platform for screening nad+ binding proteins in a cellular context | |
| Weiwer et al. | ML238: an antimalarial small molecule of a unique structural class | |
| Kubota | Development of Nucleoside Analogs and Probes for the Exploration of RNA Biology | |
| HK1248674A1 (en) | Selective pi3k delta inhibitors | |
| HK1248674B (en) | Selective pi3k delta inhibitors | |
| Lim | Discovery of Inhibitors of a Protein? RNA (Lin28-let-7) Interaction and Antimalarial Agents Through the Development of High-Throughput Screening |